Third strike for Wockhardt as API facility hit with US import alert

By Dan Stanton

- Last updated on GMT

Image: iStock/suvisuni
Image: iStock/suvisuni

Related tags Import alert Food and drug administration Pharmaceutical drug

The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.

The plant located in Ankleshwar, in the Gujarat region of India makes bulk active pharmaceutical ingredients (APIs) but a US Food and Drug Administration (FDA) import alert issued on Friday means the products are now banned from being exported to the US.

In a filing to the Bombay Stock Exchange, Wockhardt acknowledged the US FDA has updated the Import Alert 66-40 to include its API unit and said it was awaiting official communication from the US FDA on this matter.

The FDA’s actions come following an inspection last year which resulted in a Form 483, highlighting a number of manufacturing concerns.

“The Company has already initiated required steps to address the concerns raised by USFDA and is putting all efforts to resolve the matter,”​ Wockhardt added.

The API plant is the third Wockhardt facility to be banned from sending products to the US.

The company’s Waluj​ and Chikalthana​ finished formulation plants – both in Aurangabad, Maharashtra – were hit with an import alert, with products made at the sites placed under Detention Without Physical Examination (DWPE) by the FDA, in 2013.

Shares in Wockhardt fell by nearly 14% Monday, following the FDA’s announcement.

Related news

Show more

Related products

A Guide Through the API Drug Development Pipeline.

A Guide Through the API Drug Development Pipeline.

Content provided by Lonza Small Molecules | 04-Apr-2023 | Insight Guide

With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Related suppliers

Follow us

Products

View more

Webinars